Gilead, Sanofi would tank in Bioethics International’s new Good Pharma Scorecard
Bioethics International just completed a study on transparency in the biopharmaceutical industry - and found it stunningly lacking, with Gilead and Sanofi the most egregious offenders. As a result, it's set up a new "Good Pharma Scorecard" to evaluate the ethics and legalities of drug approval.